A loss-of-function variant in ASGR1 (an intronic 12-base-pair deletion (del12)) confers a larger effect on CAD risk than is predicted by its effect on non-HDL-cholesterol in humans [2], suggesting non-lipid pathways also contribute to its athero-protective properties. This evidence concerns the gene ASGR1 and coronary artery disorder.